Medical Oncologists/ Wolfram Samlowski, MD, FACP


WOLFRAM SAMLOWSKI, MD, FACP

EDUCATION
Dr. Samlowski earned his bachelor’s and medical degree from Ohio State University in Columbus, Ohio. He completed his internal medicine residency at Wayne State University in Detroit, and his hematology oncology fellowship at the University of Utah in Salt Lake City.

AREAS OF SPECIAL INTEREST
Melanoma and Renal Cancer

EXPERIENCE
Prior to joining CCCN, Dr. Samlowski served as director of Translational Research, Multidisciplinary Melanoma program at the Huntsman Cancer Institute. He was professor of Oncology and adjunct professor of pathology and dermatology at the University of Utah, in Salt Lake City, where he worked from 1984 to 2007. In 2007, he joined the Nevada Cancer Institute as Chief Section of Melanoma, Renal Cancer and Immunotherapy. He also was appointed professor of oncology. Dr. Samlowski has a teaching appointment as Clinical Professor at the University of Nevada, Reno.

PERSONAL
Dr. Samlowski and his wife Suzanne recently celebrated their 30th anniversary. They have 3 grown children. Hobbies include skiing, coaching soccer, and travel.

BOARD CERTIFIED
Medical Oncology
Internal Medicine

MEMBERSHIPS IN PROFESSIONAL ASSOCIATIONS
Fellow, American College of Physicians
American Federation of Clinical Research
American Association for Immunology
American Society for Clinical Oncology
American Association for Cancer Research
International Society for Biological Therapy of Cancer
Society of Pigment Cell and Melanoma Research

PUBLICATIONS
Hersh EM, O’Day SJ, Gonzales R, Ribas A, Samlowski WE, Gordon MS, Shechter D, Clawson A, Hawkins MJ.  “A phase II trial of nab-paclitaxel in previously treated and chemotherapy naïve patients with metastatic malignant melanoma.”  Cancer. 28;116:155-163, 2010.  Read more.

Samlowski WE, Moon J, Tuthill RJ, Heinrich MC, Balzer-Haas NS, Merl SA, DeConti RC , Thompson JA, Witter MT, Flaherty LE, Sondak VK.  “A phase II trial of imatinib mesylate in Merkel cell carcinoma (neuroendocrine carcinoma of the skin):  A Southwest Oncology Group phase II Study (S0331).”  Am J Clin Oncol 33:495-499, 2010.  Read more.

Samlowski EE, Dechet C, Weissman A, Samlowski WE.  “Large cell non-Hodgkin’s lymphoma masquerading as renal carcinoma with IVC thrombosis: A case report.” Journal of Med Case Repts 5:245, 2011.  Read more.

Eroglu Z, Kong M, Jakowatz JG, Akerly W, Samlowski W, Fruehauf JP.  “Phase II clinical trial evaluating docetaxel, vinorelbine and GM-CSF in stage IV melanoma.” Cancer Chemother Pharmacol 68:1081-1087, 2011.  Read more.

Gonsalves-Shapiro D, Samlowski WE.  “Management of melanoma brain metastases in the era of targeted therapy.” In: Melanoma: From Research to Treatment, Ascierto, PA, Kirkwood, JA, Marincola F, Palmieri G., eds, Hinawi, New York, J Skin Cancer. 2011;2011:845863. Epub 2011 Dec 15.  Read more.

Vogelzang NJ, Benowitz SI, Adams S, Aghajanian C, Chang SM, Dreyer ZE, Janne PA, Ko AH, Masters GA, Odenike O, Patel JD, Roth BJ, Samlowski WE, Seidman AD, Tap WD, Temel JS, Von Roenn JH, Kris MG. “Clinical cancer advances 2011: Annual report on progress against cancer from the American Society of Clinical Oncology.”  J Clin Oncol. 30:88-109, 2012.  Read more.

TREATMENT CENTER
Southwest

WIKIPEDIA
You can find more information about Dr. Samlowski on Wikipedia.